Maria Cristina Squilloni’s journey began with a cervical cancer diagnosis in February 2020. Following a radical hysterectomy, regular follow-ups with her gynecologic oncologist seemed routine. However, during one appointment, Mrs. Squilloni voiced her concerns about feeling unwell again, suspecting a recurrence. An examination revealed what her doctor believed to be a small vaginal cyst, an issue he deemed minor and suggested monitoring. This initial dismissal, a scenario not uncommon even in urgent care settings where thorough cancer evaluations might be overlooked, marked the beginning of a more complex chapter in Mrs. Squilloni’s health journey.
Alt text: Maria Cristina Squilloni, a cervical cancer survivor in Miami, shares her story.
Two months passed, and the cyst grew significantly, causing increased pressure on Mrs. Squilloni’s bladder. The discomfort escalated, leading to frequent and urgent urination. Preparing for a three-month trip to Italy to visit family, Mrs. Squilloni sought further reassurance from her oncologist. Again, her concerns were seemingly downplayed, attributed possibly to post-surgical side effects. Nevertheless, a Pap smear and biopsy were conducted as precautionary measures before her departure. The Pap smear returned normal, and Mrs. Squilloni proceeded with her travel plans to Italy, believing her health concerns were addressed.
Shortly after settling in Italy, a call from her oncologist delivered unexpected and concerning news. The biopsy results indicated a recurrence of cervical cancer in her vagina. While her symptoms had raised suspicions, the confirmation was still a shock. When she inquired about returning immediately for treatment, she was advised not to worry and to wait until her planned return in late August. Unbeknownst to Mrs. Squilloni at the time, a critical detail about the extent of her condition was omitted from this conversation, highlighting the potential for miscommunication or oversight in medical follow-ups, even beyond the scope of an urgent care center visit.
Cervical Cancer: From Leading Killer to Manageable Condition
Cervical cancer, once the leading cause of cancer deaths among women in the U.S., has seen a significant decline in both incidence and mortality over the past four decades, according to the American Society of Clinical Oncology (ASCO). This progress is largely attributed to increased screening through Pap smears and preventative measures like the HPV vaccine. However, despite advancements, an estimated 14,100 U.S. women will still be diagnosed with invasive cervical cancer this year, emphasizing the continued need for vigilance and early detection.
A Worsening Diagnosis and the Need for Specialized Care
Alt text: Maria Squilloni during her cancer treatment journey, highlighting the emotional and physical challenges.
During her summer stay in Italy, Mrs. Squilloni’s symptoms worsened. The bladder pressure intensified, accompanied by vaginal pain and intermittent spotting. Upon her return to Miami in August, she immediately visited her oncologist in Broward County. An examination revealed the cancerous mass had grown to five centimeters. Radiation therapy was recommended, and a consultation with a radiologist was scheduled.
It was during this radiology appointment that Mrs. Squilloni received the most devastating news. Reviewing her CT scan, which she herself hadn’t seen, the radiologist pointed out spots indicating metastatic cancer – the cervical cancer had spread to her lung. The radiologist explained that chemotherapy, not radiation, was now necessary. The shock of this advanced diagnosis was overwhelming, a stark contrast to the initial downplaying of her symptoms and a testament to how easily a serious condition can be underestimated, even in settings beyond an urgent care center’s scope of practice for cancer diagnosis. Recognizing the gravity of the situation, Mrs. Squilloni knew she needed to seek the highest quality cancer care available.
Choosing Miami Cancer Institute: A Hometown Beacon of Hope
Alt text: Miami Cancer Institute, a leading cancer treatment center in Miami, Florida.
Driven by the need for expert intervention, Mrs. Squilloni researched leading cancer centers nationwide. Miami Cancer Institute, part of Baptist Health, emerged as her top choice. Its location as her “hometown” cancer center was a significant factor, among many others. Positive online reviews from former patients, including international individuals, further solidified her decision. Her first visit to Miami Cancer Institute left a lasting impression. The dedicated facility, solely focused on cancer treatment and comprehensive patient support services, offered a sense of hope and reassurance.
Mrs. Squilloni entrusted her care to Dr. Eleftheria Kalogera, a gynecologic oncologist at Miami Cancer Institute. From their first meeting in September, Mrs. Squilloni felt a strong connection with Dr. Kalogera. Her empathetic nature, clear communication, and honest yet hopeful approach instilled confidence.
Alt text: Dr. Eleftheria Kalogera, a gynecologic oncologist at Miami Cancer Institute, dedicated to patient-centered care.
Dr. Kalogera remembers Mrs. Squilloni’s initial appointment vividly. Just three weeks after the confirmation of recurrent metastatic cervical cancer, it was clear aggressive systemic treatment was crucial. Dr. Kalogera recommended immediate action, and Mrs. Squilloni, feeling strong and determined, agreed.
Immunotherapy: A Vital Addition to Her Treatment Plan
Driven to understand her condition and treatment options, Mrs. Squilloni researched cervical cancer therapies. She discovered the promising role of immunotherapy for certain cancer types. Fortuitously, a recent study highlighted the improved outcomes for patients with recurrent metastatic cervical cancer when immunotherapy was added to the treatment regimen. Dr. Kalogera and the Miami Cancer Institute’s multidisciplinary tumor board concurred that immunotherapy would be beneficial in Mrs. Squilloni’s case. Her treatment plan was adjusted to include immunotherapy alongside standard chemotherapy for six rounds, followed by two rounds of immunotherapy alone, with the option to continue immunotherapy maintenance.
By March 30th, Mrs. Squilloni completed her treatment and was declared disease-free. Dr. Kalogera emphasized the significance of having new medications like immunotherapy that can be integrated early in treatment to enhance patient outcomes.
Embracing Integrative Health and a New Lifestyle
Alt text: Maria Squilloni embracing an integrative approach to health, including healthy eating and lifestyle changes post-cancer treatment.
While elated by the “disease-free” status, Mrs. Squilloni remained grounded, understanding the complexities of metastatic cancer. Beyond medical treatment, she embraced a complete lifestyle overhaul to mitigate the toxic effects of chemotherapy and bolster her body’s resilience. This included significant changes to her diet, lifestyle, and supplement intake. Seeking further support, Mrs. Squilloni traveled to Germany for an integrative health clinic, focusing on strengthening her body’s natural defenses against recurrence. Dr. Kalogera supported this integrative approach, incorporating diet, exercise, acupuncture, and massage into Mrs. Squilloni’s overall care.
Mrs. Squilloni adopted a primarily vegetarian, organic diet, eliminating carbs, meats, sugar, and dairy, and even installed a water filter, believing in the interconnectedness of diet and cellular health.
Alt text: A focus on organic fruits and vegetables as part of a cancer survivor’s healthy diet.
Dr. Kalogera acknowledged Mrs. Squilloni’s initial reservations about solely relying on Western medicine. However, through their collaborative relationship and Miami Cancer Institute’s comprehensive approach, Mrs. Squilloni developed trust and acceptance. Dr. Kalogera values understanding her patients’ perspectives and aligning treatment with their values, fostering a learning environment for both doctor and patient.
Navigating cancer survivorship during a pandemic, Mrs. Squilloni prioritized outdoor activities, beach visits, park outings, and quality time with loved ones. Her experience instilled a deeper appreciation for life and a commitment to intentionally spending her time.
A Young Neighbor’s Inspiring Act of Support
Alt text: Maria Squilloni and her young neighbor Nell, showcasing community support for cancer survivors.
Hair loss, a common side effect of cancer treatment, occurred before Mrs. Squilloni’s son’s birthday. A wig felt uncomfortable and unnatural. Choosing to embrace her baldness, she found an unexpected source of support in her 13-year-old neighbor, Nell. Nell, known for her exceptionally long hair, decided to cut and donate it to Locks of Love in honor of Mrs. Squilloni’s cancer journey. This powerful gesture of solidarity inspired Mrs. Squilloni to share her story publicly.
Currently in her hometown of Formia, Italy, celebrating her 50th birthday, Mrs. Squilloni remains under Dr. Kalogera’s close follow-up. Dr. Kalogera reports Mrs. Squilloni’s excellent progress and her remarkable response to treatment, highlighting the rewarding nature of her care.
Dr. Kalogera emphasizes the critical importance of cervical cancer vigilance for all women. Annual exams, adherence to Pap smear recommendations, and HPV vaccination for both boys and girls starting at age nine are crucial. Prompt medical attention for any unusual symptoms remains paramount for early cancer detection and improved outcomes. Mrs. Squilloni’s journey underscores the significance of persistent self-advocacy, the vital role of expert and compassionate care, and the hopeful possibilities even after a potentially missed or delayed initial diagnosis, reinforcing the importance of seeking specialized care beyond initial assessments, even those potentially encountered in an urgent care center setting in Miami.
